Tessa Malamud-Cohen is a Dutch native, living in Israel, employed since 2010 by the Swiss company Ferring Pharmaceuticals at their wholly-owned subsidiary Bio-Technology General (Israel) Ltd. She has been active in the IP field for almost 30 years, most of which as in-house counsel in the pharmaceutical industry (and 3 years in private practice).
Tessa has a B.Sc. and a M.Sc. in biology and microbiology, respectively, from the Hebrew University of Jerusalem and is both a licensed European and Israeli patent attorney. She has worked in both the innovative and generic pharmaceutical industry in both Israel and in the Netherlands: Bio-Technology General 1992-1999, Teva Pharmaceuticals 1999-2001, N.V. Organon 2002-2006 and Ferring Pharmaceuticals 2010 until now. From 2006-2009 she was employed by the IP firm Reinhold Cohn & Partners, from 2008 as partner.
Tessa has extensive experience in several jurisdictions, including managing multijurisdictional litigations especially in Europe and the US where she leads multinational legal teams.
She also has extensive experience in patentability assessments, drafting of patent applications, worldwide patent prosecution, conducting oppositions (IL, EP), infringement assessments, due diligence investigations relating to patent disputes and potential in-licensing projects, freedom-to-operate assessments, validity assessments, patent portfolio management, drug product lifecycle management, and licensing.
Tessa was named Corporate IP Star by MIP for six consecutive years from 2015-2020 and World’s Leading Strategist by IAM 300 for three consecutive years from 2018-2020.
She is a member of the European Patent Institute (epi), the International Association for the Protection of Intellectual Property (AIPPI), the Licensing Executives Society (LES) (of which she is a former Member of the Committee), the Association of Israel Patent Attorneys and the International Intellectual Property Law Association (IIPLA).